Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via ß-cell function improvement and insulin resistance reduction.

Zhu, Tiantian; Li, Minghui; Zhu, Moli; Liu, Xu; Huang, Keke; Li, Wenru; Wang, Shuang-Xi; Yin, Yaling; Li, Peng

Zhu, Tiantian; Li, Minghui; Zhu, Moli; Liu, Xu; Huang, Keke; Li, Wenru; Wang, Shuang-Xi; Yin, Yaling; Li, Peng.

Afiliación

Zhu T; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Li M; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.
Zhu M; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.
Liu X; These authors contributed equally to this work.
Huang K; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Li W; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.
Wang SX; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.
Yin Y; These authors contributed equally to this work.
Li P; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.

Iran J Basic Med Sci ; 25(4): 483-488, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35656076

Palabras clave

Epigallocatechin-3-gallate; Insulin resistance; Insulin secretion; Pancreatic duodenal - homeobox protein-1; Type 2 diabetes mellitus; ß-cell

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Iran J Basic Med Sci Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google